Finfluencers in Sweden: What the new regulatory landscape means for financial firms
Financial influencers, or ‘finfluencers’, have quietly become one of the most influential distribution channels in Sweden - more than one in five young adults trust financial information from finfluencers in the region. We explore the emerging risks.
Regulatory Unwrapped: How can firms win the conduct and culture war?
From the three lines of defence to voice surveillance and cross-border accountability, tune in as industry experts unpack the evolving landscape of conduct risk and what it means for firms in 2026.
Regulatory Unwrapped: Breaking down the FCA’s NFM framework
Join us for a deeper dive into the biggest regulatory trends and challenges firms are facing as we chat with experts and understand how organizations can keep pace with fast-paced compliance changes.
Regulatory Wrap episode 81: 2026 Surveillance Benchmarking Report
In Regulatory Wrap for the week to May 22, Jennie Clarke unpacks the top findings from 1LoD’s newly published 2026 surveillance benchmarking report.
Regulatory Wrap episode 80: The FCA vs. Finfluencers
In Regulatory Wrap for the week to May 1, Aarti Agarwal discusses the FCA’s latest enforcement approach against unauthorized financial promotions on social media.
How to bring pharma sales reps’ communications into compliance
Pharma sales reps operate in high-pressure environments where they're judged on availability and responsiveness. Organizations have invested heavily in tools to support field teams, but that efficiency pressures creates a persistent temptation to cut corners on compliant communications.
Regulatory Wrap Episode 71: FDA takes aim at pharma companies’ social media activity
In Regulatory Wrap for the week to October 3, Ryan Thaxton explores the growing spotlight on pharma companies’ social media activity.
ESG compliance regulations and compliance strategies
Environmental, social, and governance (ESG) mandates are reshaping how organizations approach regulatory compliance amid growing demand for sustainable practices across all sectors. So how can organizations adapt their compliance strategies to meet ESG mandates and stakeholder expectations?
FDA takes aim at pharmaceuticals’ social media activity
The FDA is turning its eye towards pharmaceuticals’ social media use. Review the laws and regulations triggering FDA warning letters and how to stay compliant.
The Source Podcast: Teamwork makes the dream work – How to get employee buy-in on compliance
In this episode of The Source podcast, we explore why firms are struggling to get employees to stick to compliance rules and to set the right "tone from the top" for them to follow. Featuring special guest conduct, culture, and risk expert Emma Parry.
Regulatory Wrap episode 64: Global regulators crack down on finfluencer violations
In Regulatory Wrap for the week to June 20, Kathryn Fallah covers the international crackdown on financial influencers, also known as “finfluencers.”